Vitamin D supplementation during pregnancy: Improvements in birth outcomes and complications through direct genomic alteration

Molecular and Cellular Endocrinology

Volumn 453, Issue , 2017, Pages 113-130

  Hollis, Bruce W ^a   Wagner, Carol L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Asthma; Cholecalciferol; Complications of pregnancy; Genomics; Health outcomes; Preeclampsia; Pregnancy; Vitamin D

Indexed keywords

VITAMIN D;

ASTHMA; AUTOIMMUNE DISEASE; CALCIUM HOMEOSTASIS; COMPARATIVE STUDY; CONCEPTION; DRUG NOMENCLATURE; GENE EXPRESSION; GENE MUTATION; GENOMICS; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; THERAPY EFFECT; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; CLASSIFICATION; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; FETUS; METABOLISM; NEWBORN; PHYSIOLOGY; PREGNANCY; VITAMIN D DEFICIENCY;

ASTHMA; DIETARY SUPPLEMENTS; FEMALE; FETUS; GENE EXPRESSION; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85013466626     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2017.01.039     Document Type: Review

References (162)

1. Abrams, S.A., Vitamin D supplementation during pregnancy. J. Bone Min. Res. 26:10 (2011), 2338–2340.
2. Ajibade, D.V., Dhawan, P., Fechner, A.J., Meyer, M.B., Pike, J.W., Christakos, S., Evidence for a role of prolactin in calcium homeostasis: regulation of intestinal transient receptor potential vanilloid type 6, intestinal calcium absorption, and the 25-hydroxyvitamin D(3) 1alpha hydroxylase gene by prolactin. Endocrinology 151:7 (2010), 2974–2984.
3. Akour, A.A., Gerk, P., Kennedy, M.J., Megalin expression in human term and preterm placental villous tissues: effect of gestational age and sample processing and storage time. J. Pharmacol. Toxicol. Methods 71 (2015), 147–154.
4. Al-Garawi, A., Carey, V.J., Chhabra, D., Mirzakhani, H., Morrow, J., Lasky-Su, J., et al. The role of vitamin D in the transcriptional program of human pregnancy. PLoS One, 11(10), 2016, e0163832.
5. Anderson, C.M., Ralph, J.L., Johnson, L., Scheett, A., Wright, M.L., Taylor, J.Y., et al. First trimester vitamin D status and placental epigenomics in preeclampsia among Northern Plains primiparas. Life Sci. 129 (2015), 10–15.
6. Antia, A.V., Wiltse, H.E., Rowe, R.D., Pitt, E.L., Levin, S., Ottesen, O.E., et al. Pathogenesis of the supravalvular aortic stenosis syndrome. J. Pediatr. 71 (1967), 431–441.
7. Aravena, T., Castillo, S., Carrasco, X., Mena, I., Lopez, J., Rojas, J.P., et al. Williams syndrome: clinical, cytogenetical, neurophysiological and neuroanatomic study. Rev. Med. Child. 130 (2002), 631–637.
8. Baca, K.M., Simhan, H.N., Platt, R.W., Bodnar, L.M., Low maternal 25-hydroxyvitamin D concentration increases the risk of severe and mild preeclampsia. Ann. Epidemiol. 26:12 (2016), 853–857 e1.
9. Baker, A.M., Haeri, S., Camargo, C.A. Jr., Espinola, J.A., Stuebe, A.M., A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J. Clin. Endocrinol. Metab. 95:11 (2010), 5105–5109.
10. Becroft, D.M.O., Chambers, D., Supravalvular aortic stenosis-infantile hypercalcemia syndrome: in vitro hypersensitivity to vitamin D and calcium. J. Med. Genet. 13 (1976), 223–228.
11. Bell, N.H., Stern, P.H., Pantzer, E., Sinha, T.K., DeLuca, H.F., Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J. Clin. Invest. 64:1 (1979), 218–225.
12. Berlanga-Taylor, A.J., Disanto, G., Ebers, G.C., Ramagopalan, S.V., Vitamin D-gene interactions in multiple sclerosis. J. Neurol. Sci. 311:1–2 (2011), 32–36.
13. Bikle, D.D., Gee, E., Halloran, B., Haddad, J.G., Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J. Clin. Invest. 74:6 (1984), 1966–1971.
14. Black, J., Bonham-Carter, J., Association between aortic stenosis and facies of severe infantile hypercalcemia. Lancet 2 (1963), 745–749.
15. Bodnar, L.M., Simhan, H.N., Vitamin D may be a link to black-white disparities in adverse birth outcomes. Obstet. Gynecol. Surv. 65:4 (2010), 273–284.
16. Bodnar, L.M., Catov, J.M., Simhan, H.N., Holick, M.F., Powers, R.W., Roberts, J.M., Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metabol. 92:9 (2007), 3517–3522.
17. Bodnar, L.M., Catov, J.M., Roberts, J.M., Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am. J. Obstet. Gynecol. 196(4):324 (2007), e1–5.
18. Bodnar, L.M., Krohn, M.A., Simhan, H.N., Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J. Nutr. 139:6 (2009), 1157–1161.
19. Bodnar, L.M., Simhan, H.N., Catov, J.M., Roberts, J.M., Platt, R.W., Diesel, J.C., et al. Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology 25:2 (2014), 207–214.
20. Bouillon, R., Van Baelen, H., Transport of vitamin D: significance of free and total concentrations of the vitamin D metabolites. Calcif. Tissue Int. 33:5 (1981), 451–453.
21. Bouillon, R., van Baelen, H., de Moor, P., Comparative study of the affinity of the serum vitamin D-binding protein. J. Steroid Biochem. 13:9 (1980), 1029–1034.
22. Brannon, P.M., Picciano, M.F., Vitamin D in pregnancy and lactation in humans. Annu. Rev. Nutr. 31 (2011), 89–115.
23. Brehm, J.M., Celedon, J.C., Soto-Quiros, M.E., Avila, L., Hunninghake, G.M., Forno, E., et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am. J. Respir. Crit. care Med. 179:9 (2009), 765–771.
24. Brehm, J.M., Schuemann, B., Fuhlbrigge, A.L., Hollis, B.W., Strunk, R.C., Zeiger, R.S., et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol., 126(1), 2010 52–8 e5.
25. Calton, E.K., Keane, K.N., Newsholme, P., Soares, M.J., The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One, 10(11), 2015, e0141770.
26. Camargo, C.A. Jr., Ingham, T., Wickens, K., Thadhani, R., Silvers, K.M., Epton, M.J., et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics, 127(1), 2011 e180–e7.
27. Cannell, J.J., Autism and vitamin D. Med. Hypotheses 70:4 (2008), 750–759.
28. Carneiro, R.M., Prebehalla, L., Tedesco, M.B., Sereika, S.M., Hugo, M., Hollis, B.W., et al. Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnover. J. Clin. Endocrinol. Metab. 95:4 (2010), 1767–1776.
29. Chawes, B.L., Bonnelykke, K., Stokholm, J., Vissing, N.H., Bjarnadottir, E., Schoos, A.M., et al. Effect of vitamin D3 supplementation during pregnancy on risk of persistent wheeze in the offspring: a randomized clinical trial. JAMA 315:4 (2016), 353–361.
30. Chen, J., Xin, K., Wei, J., Zhang, K., Xiao, H., Lower maternal serum 25(OH) D in first trimester associated with higher autism risk in Chinese offspring. J. Psychosom. Res. 89 (2016), 98–101.
31. Cooper, C., Harvey, N.C., Bishop, N.J., Kennedy, S., Papageorghiou, A.T., Schoenmakers, I., et al. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. lancet Diabetes & Endocrinol. 4:5 (2016), 393–402.
32. De-Regil, L.M., Palacios, C., Ansary, A., Kulier, R., Pena-Rosas, J.P., Vitamin D supplementation for women during pregnancy. Cochrane database Syst. Rev., 2, 2012, CD008873.
33. Dobson, R., Giovannoni, G., Ramagopalan, S., The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J. Neurol., Neurosurg. psychiatry 84:4 (2013), 427–432.
34. Ebers, G., Interactions of environment and genes in multiple sclerosis. J. Neurol. Sci. 334:1–2 (2013), 161–163.
35. Eichholzer, M., Platz, E.A., Bienstock, J.L., Monsegue, D., Akereyeni, F., Hollis, B.W., et al. Racial variation in vitamin D cord blood concentration in white and black male neonates. Cancer Causes Control 24:1 (2013), 91–98.
36. Fabri, M., Stenger, S., Shin, D.M., Yuk, J.M., Liu, P.T., Realegeno, S., et al. Vitamin D is required for IFN-{gamma}-mediated antimicrobial activity of human macrophages. Sci. Transl. Med., 3(104), 2011 104ra2.
37. Faulkner, J.L., Cornelius, D.C., Amaral, L.M., Harmon, A.C., Cunningham, M.W. Jr., Darby, M.M., et al. Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310:4 (2016 Feb 15), R346–R354, 10.1152/ajpregu.00388.2015 [Epub 2015 Dec16].
38. Flanagan, J.N., Young, M.V., Persons, K.S., Wang, L., Mathieu, J.S., Whitlatch, L.W., et al. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res. 26:4A (2006), 2567–2572.
39. Friedman, W.F., Vitamin D as a cause of the supravalvular aortic stenosis syndrome. Am. Heart J. 73 (1967), 718–720.
40. Friedman, W.F., Roberts, W.C., Vitamin D and the supravalvular aortic stenosis syndrome. The transplacental effects of vitamin D on the aorta of the rabbit. Circulation 34 (1966), 77–86.
41. Garabedian, M., Jacqz, E., Guillozo, H., Grimberg, R., Guillot, M., Gagnadoux, M.F., et al. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. N. Engl. J. Med. 312:15 (1985), 948–952.
42. Garcia, R.E., Friedman, W.F., Kaback, M., Rowe, R.D., Idiopathic hypercalcemia and supravalvular aortic stenosis: documentation of a new syndrome. N. Engl. J. Med. 271 (1964), 117–120.
43. Gernand, A.D., Bodnar, L.M., Klebanoff, M.A., Parks, W.T., Simhan, H.N., Maternal serum 25-hydroxyvitamin D and placental vascular pathology in a multicenter US cohort. Am. J. Clin. Nutr. 98:2 (2013), 383–388.
44. Gernand, A.D., Simhan, H.N., Baca, K.M., Caritis, S., Bodnar, L.M., Vitamin D, pre-eclampsia, and preterm birth among pregnancies at high risk for pre-eclampsia: an analysis of data from a low-dose aspirin trial. BJOG, 2016 October 5.
45. Gibson, C.C., Davis, C.T., Zhu, W., Bowman-Kirigin, J.A., Walker, A.E., Tai, Z., et al. Dietary vitamin D and its metabolites non-genomically stabilize the endothelium. PLoS One, 10(10), 2015, e0140370.
46. Gibson, C.C., Zhu, W., Davis, C.T., Bowman-Kirigin, J.A., Chan, A.C., Ling, J., et al. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 131:3 (2015), 289–299.
47. Goldring, S.T., Griffiths, C.J., Martineau, A.R., Robinson, S., Yu, C., Poulton, S., et al. Prenatal vitamin d supplementation and child respiratory health: a randomised controlled trial. PLoS One, 8(6), 2013, e66627.
48. Gould, J.F., Anderson, A.J., Yelland, L.N., Smithers, L.G., Skeaff, C.M., Zhou, S.J., et al. Association of cord blood vitamin D with early childhood growth and neurodevelopment. J. Paediatr. Child. Health 53:1 (2017 Jan), 75–83, 10.1111/jpc.13308 [Epub 2016, Aug 27].
49. Grant, C.C., Crane, J., Mitchell, E.A., Sinclair, J., Stewart, A., Milne, T., et al. Vitamin D supplementation during pregnancy and infancy reduces aeroallergen sensitization: a randomized controlled trial. Allergy 71:9 (2016), 1325–1334.
50. Greenberg, B.M., Vitamin D during pregnancy and multiple sclerosis: an evolving association. JAMA Neurol. 73:5 (2016), 498–499.
51. 2. J. Pediatr. 105 (1984), 61–64.
52. Grotegut, C.A., Prevention of preeclampsia. J. Clin. Invest. 126:12 (2016 Dec 1), 4396–4398, 10.1172/JCI91300 [Epub 2016 Nov 14].
53. Haddad, J.G., Hillman, L., Rojanasathit, S., Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol. J. Clin. Endocrinol. Metab. 43:1 (1976), 86–91.
54. Haddad, J.G., Matsuoka, L.Y., Hollis, B.W., Hu, Y., Wortsman, J., Human plasma transport of vitamin D after its endogenous synthesis. J. Clin. Invest. 91:6 (1993), 2552–2555.
55. Heaney, R.P., Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr. Rev. 72:1 (2014), 48–54.
56. Heaney, R.P., Is vitamin D inadequacy in early life an instance of the “Barker hypothesis. Nutr. Today 51:1 (2016), 14–17.
57. Heaney, R., Davies, K., Chen, T., Holick, M., Barger-Lux, M., Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77 (2003), 204–210.
58. Heaney, R.P., Armas, L.A., Shary, J.R., Bell, N.H., Binkley, N., Hollis, B.W., 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am. J. Clin. Nutr. 87:6 (2008), 1738–1742.
59. Hensel, K.J., Randis, T.M., Gelber, S.E., Ratner, A.J., Pregnancy-specific association of vitamin D deficiency and bacterial vaginosis. Am. J. Obstet. Gynecol. 204(1):41 (2011), e1–9.
60. Heubi, J.E., Hollis, B.W., Specker, B., Tsang, R.C., Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology 9:2 (1989), 258–264.
61. Holick, M.F., The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J. Invest. Dermatol. 77:1 (1981), 51–58.
62. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96:7 (2011 Jul), 1911–1930, 10.1210/jc.2011-0385 [Epub 2011 Jun 6].
63. 3 intestinal absorption in vivo: influence of fatty acids, bile salts, and perfusate pH on absorption. Gut 19 (1978), 267–272.
64. Hollis, B.W., Comparison of equilibrium and disequilibrium assay conditions for ergocalceferol, cholecaliferol and their major metabolites. J. Steroid Biochem., 1984, 81–86.
65. Hollis, B., Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135 (2005), 317–322.
66. Hollis, B., Wagner, C., Assessment of dietary vitamin D requirements during pregnancy and Lactation. Am. J. Clin. Nutr. 79 (2004), 717–726.
67. Hollis, B.W., Wagner, C.L., Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J. Clin. Endocrinol. Metab. 98:12 (2013), 4619–4628.
68. Hollis, B.W., Wagner, C.L., Vitamin d and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif. Tissue Int. 92:2 (2013), 128–139.
69. Hollis, B.W., Wagner, C.L., The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J. Clin. Endocrinol. Metab. 98:12 (2013), 4619–4628.
70. Hollis, B.W., Lowery, J.W., Pittard, W.B. 3rd, Guy, D.G., Hansen, J.W., Effect of age on the intestinal absorption of vitamin D3-palmitate and nonesterified vitamin D2 in the term human infant. J. Clin. Endocrinol. Metab. 81:4 (1996), 1385–1388.
71. Hollis, B.W., Johnson, D., Hulsey, T.C., Ebeling, M., Wagner, C.L., Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. Journal of bone and mineral research: Off. J. Am. Soc. Bone Miner. Res. 26:10 (2011), 2341–2357.
72. Hosseinpour, F., Wikvall, K., Porcine microsomal vitamin D(3) 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6. J. Biol. Chem. 275:44 (2000), 34650–34655.
73. Hou, W., Yan, X.T., Bai, C.M., Zhang, X.W., Hui, L.Y., Yu, X.W., Decreased serum vitamin D levels in early spontaneous pregnancy loss. Eur. J. Clin. Nutr. 70:9 (2016), 1004–1008.
74. Jones, A.R., Shusta, E.V., Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm. Res. 24:9 (2007), 1759–1771.
75. Karlgren, M., Miura, S., Ingelman-Sundberg, M., Novel extrahepatic cytochrome P450s. Toxicol. Appl. Pharmacol. 207:2 Suppl. l (2005), 57–61.
76. Kiely, M.E., Zhang, J.Y., Kinsella, M., Khashan, A.S., Kenny, L.C., Vitamin D status is associated with uteroplacental dysfunction indicated by pre-eclampsia and small-for-gestational-age birth in a large prospective pregnancy cohort in Ireland with low vitamin D status. Am. J. Clin. Nutr. 104:2 (2016), 354–361.
77. Kiely M, Zhang J, Kinsella M, Khashan A, Kenny L, editors. Vitamin D Status is Associated with Utero-placental Dysfunction in a Large Prospective Pregnancy Cohort with Low 25(OH)D3 and Ubiquitous 3-epi-25(OH)D3 and 25(OH)D3 and 25(OH)D2. The Vitamin D Workshop; 2016 May 29-31, 2016; Boston, MA: http://www.vitamindworkshop.org/.
78. Kissmeyer, A., Mathiasen, I.S., Latini, S., Binderup, L., Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP). Endocrine 3:4 (1995), 263–266.
79. Kovacs, C.S., The role of vitamin D in pregnancy and lactation: insights from animal models and clinical studies. Annu. Rev. Nutr. 32:1 (2012), 97–123.
80. Kovacs, C.S., Woodland, M.L., Fudge, N.J., Friel, J.K., The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice. Am. J. Physiol. Endocrinol. Metabol. 289:1 (2005), E133–E144.
81. Kumar, R., Cohen, W.R., Silva, P., Epstein, F.H., Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J. Clin. Invest. 63:2 (1979), 342–344.
82. Lagishetty, V., Liu, N.Q., Hewison, M., Vitamin D metabolism and innate immunity. Mol. Cell. Endocrinol. 347:1–2 (2011), 97–105.
83. LaMarca, B., Amaral, L.M., Harmon, A.C., Cornelius, D.C., Faulkner, J.L., Cunningham, M.W. Jr., Placental ischemia and resultant phenotype in animal models of preeclampsia. Curr. Hypertens. Rep., 18(5), 2016, 38.
84. 2 on pregnancy in the rat. Fertil. Steril. 12 (1961), 343–345.
85. Lindqvist, P.G., Silva, A.T., Gustafsson, S.A., Gidlof, S., Maternal vitamin D deficiency and fetal distress/birth asphyxia: a population-based nested case-control study. BMJ Open, 6(9), 2016, e009733.
86. Litonjua, A.A., Childhood asthma may be a consequence of vitamin D deficiency. Curr. Opin. Allergy Clin. Immunol. 9:3 (2009), 202–207.
87. Litonjua, A.A., Carey, V.J., Laranjo, N., Harshfield, B.J., McElrath, T.F., O'Connor, G.T., et al. Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 Years: the VDAART randomized clinical trial. JAMA 315:4 (2016), 362–370.
88. Liu, N.Q., Hewison, M., Vitamin D, the placenta and pregnancy. Arch. Biochem. Biophys. 523:1 (2012 Jul 1), 37–47, 10.1016/j.abb.2011.11.018 [Epub 2011 Dec 2].
89. Liu, P.T., Stenger, S., Li, H., Wenzel, L., Tan, B.H., Krutzik, S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:5768 (2006), 1770–1773.
90. Liu, N.Q., Kaplan, A.T., Lagishetty, V., Ouyang, Y.B., Ouyang, Y., Simmons, C.F., et al. Vitamin D and the regulation of placental inflammation. J. Immunol. 186:10 (2011), 5968–5974.
91. Liu, N.Q., Ouyang, Y., Bulut, Y., Lagishetty, V., Chan, S.Y., Hollis, B.W., et al. Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology 154:7 (2013), 2270–2280.
92. Lund, B., Selnes, A., Plasma 1,25-dihydroxyvitamin D levels in pregnancy and lactation. Acta Endocrinol. 92:2 (1979), 330–335.
93. Luxwolda, M.F., Kuipers, R.S., Kema, I.P., Janneke Dijck-Brouwer, D.A., Muskiet, F.A., Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br. J. Nutr., 2012, 1–5.
94. Luxwolda, M.F., Kuipers, R.S., Kema, I.P., van der Veer, E., Dijck-Brouwer, D.A., Muskiet, F.A., Vitamin D status indicators in indigenous populations in East Africa. Eur. J. Nutr. 52:3 (2013), 1115–1125.
95. Lykkedegn, S., Sorensen, G.L., Beck-Nielsen, S.S., Pilecki, B., Duelund, L., Marcussen, N., et al. Vitamin D depletion in pregnancy decreases survival time, oxygen saturation, Lung weight and body weight in preterm rat offspring. PLoS One, 11(8), 2016, e0155203.
96. Marzolo, M.P., Farfan, P., New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol. Res. 44:1 (2011), 89–105.
97. McGrath, J.J., Feron, F.P., Burne, T.H., Mackay-Sim, A., Eyles, D.W., Vitamin D3-implications for brain development. J. Steroid Biochem. Mol. Biol. 89–90:1–5 (2004), 557–560.
98. McGrath, J.J., Eyles, D.W., Pedersen, C.B., Anderson, C., Ko, P., Burne, T.H., et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch. General Psychiatry 67:9 (2010), 889–894.
99. McGrath, J.J., Eyles, D.W., Pedersen, C.B., Anderson, C., Ko, P., Burne, T.H., et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch. Gen. Psychiatry 67:9 (2010), 889–894.
100. Meems, L.M., Mahmud, H., Buikema, H., Tost, J., Michel, S., Takens, J., et al. Parental vitamin D deficiency during pregnancy is associated with increased blood pressure in offspring via Panx1 hypermethylation. Am. J. Physiol. Heart Circ. Physiol. 311:6 (2016 Dec 1), H1459–H1469, 10.1152/ajpheart.00141.2016 [Epub 2016 Oct 21].
101. Merewood, A., Mehta, S.D., Chen, T.C., Bauchner, H., Holick, M.F., Association between vitamin D deficiency and primary cesarean section. J. Clin. Endocrinol. Metab. 94:3 (2009), 940–945.
102. Miliku, K., Vinkhuyzen, A., Blanken, L., McGrath, J., Eyles, D., Burne, T., et al. Maternal vitamin D concentrations during pregnancy, fetal growth patterns, and risks of adverse birth outcomes. Am. J. Clin. Nutr. 103 (2016), 1514–1522.
103. The Vitamin D Workshop; 2016 March 29-31 Mirzakhani, H., Harshfield, B., Carey, V., Laranjo, N., Litonjua, A., Weiss, S., (eds.) Association of Maternal Asthma and Early Pregnancy Serum Vitamin D Level with Risk of Preeclampsia, 2016 Boston, MA http://www.vitamindworkshop.org/.
104. Mirzakhani, H., Litonjua, A.A., McElrath, T.F., O'Connor, G., Lee-Parritz, A., Iverson, R., et al. Early pregnancy vitamin D status and risk of preeclampsia. J. Clin. Invest. 126:12 (2016 Dec 1), 4702–4715, 10.1172/JCI89031 [Epub 2016 Nov 14].
105. Mojibian, M., Soheilykhah, S., Fallah Zadeh, M.A., Jannati Moghadam, M., The effects of vitamin D supplementation on maternal and neonatal outcome: a randomized clinical trial. Iran. J. Reprod. Med. 13:11 (2015), 687–696.
106. Mokry, L.E., Ross, S., Ahmad, O.S., Forgetta, V., Smith, G.D., Goltzman, D., et al. Vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLoS Med., 12(8), 2015, e1001866.
107. Morris, C.A., Mervis, C.B., William's syndrome and related disorders. Ann. Dev. Genomics Hum. Genet. 1 (2000), 461–484.
108. Munger, K.L., Aivo, J., Hongell, K., Soilu-Hanninen, M., Surcel, H.M., Ascherio, A., Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the finnish maternity cohort. JAMA Neurol. 73:5 (2016), 515–519.
109. Murthi, P., Davies-Tuck, M., Lappas, M., Singh, H., Mockler, J., Rahman, R., et al. Maternal 25-hydroxyvitamin D is inversely correlated with fetal serotonin. Clin. Endocrinol. (Oxf), 2016 Nov 12, 10.1111/cen.13281 [Epub ahead of print].
110. Nielsen, N.M., Munger, K.L., Koch-Henriksen, N., Hougaard, D.M., Magyari, M., Jorgensen, K.T., et al. Neonatal vitamin D status and risk of multiple sclerosis: a population-based case-control study. Neurology 88:1 (2017 Jan 3), 44–51, 10.1212/WNL.0000000000003454 [Epub 2016 Nov 30].
111. Novakovic, B., Sibson, M., Ng, H.K., Manuelpillai, U., Rakyan, V., Down, T., et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J. Biol. Chem. 284:22 (2009), 14838–14848.
112. Nykjaer, A., Dragun, D., Walther, D., Vorum, H., Jacobsen, C., Herz, J., et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:4 (1999), 507–515.
113. Olsen, S.F., Secher, N.J., A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br. J. Nutr. 64:3 (1990), 599–609.
114. Oxford Centre for Evidence-based Medicine-levels of Evidence, 2009 [Available from: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.
115. Pal L, Zhang H, Williams J, Santoro NF, Diamond MP, Schlaff WD, et al. Vitamin D status relates to reproductive outcome in women with polycystic ovary syndrome: secondary analysis of a multicenter randomized controlled trial. J. Clin. Endocrinol. Metabol.0(0):jc.2015-4352.
116. Parlea, L., Bromberg, I.L., Feig, D.S., Vieth, R., Merman, E., Lipscombe, L.L., Association between serum 25-hydroxyvitamin D in early pregnancy and risk of gestational diabetes mellitus. Diabet. Med. a J. Br. Diabet. Assoc. 29:7 (2012 Jul), e25–e32, 10.1111/j.1464-5491.2011.03550.
117. Patrick, R.P., Ames, B.N., Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J. 28:6 (2014), 2398–2413.
118. Patrick, R.P., Ames, B.N., Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 29:6 (2015), 2207–2222.
119. Ponchon, G., Kennan, A.L., DeLuca, H.F., “Activation” of vitamin D by the liver. J. Clin. Invest. 48:11 (1969), 2032–2037.
120. Qin, L.L., Lu, F.G., Yang, S.H., Xu, H.L., Luo, B.A., Does maternal vitamin D deficiency increase the risk of preterm birth: a meta-analysis of observational studies. Nutrients, 8(5), 2016.
121. Rasmussen, H., Wong, M., Bikle, D., Goodman, D.B., Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J. Clin. Invest. 51:9 (1972), 2502–2504.
122. Robinson, C.J., Alanis, M.C., Wagner, C.L., Hollis, B.W., Johnson, D.D., Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am. J. Obstet. Gynecol. 203(4):366 (2010), e1–6.
123. Ross, A.C., Manson, J.E., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., et al. The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J. Am. Diet. Assoc. 111:4 (2011), 524–527.
124. Sablok, A., Batra, A., Thariani, K., Batra, A., Bharti, R., Aggarwal, A.R., et al. Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome. Clin. Endocrinol. (Oxf) 83:4 (2015), 536–541.
125. Safadi, F.F., Thornton, P., Magiera, H., et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J. Clin. Invest., 103, 1999, 239.
126. Schuessler, M., Astecker, N., Herzig, G., Vorisek, G., Schuster, I., Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylases. Steroids 66:3–5 (2001), 399–408.
127. Schulz E, Cruze L, Wei W, Garrett-Meyer E, Shary J, Forestieri N, et al., editors. Effects of Maternal Vitamin D Supplementation on Placental Gene Expression (Platform Presentation). Pediatric Academic Societies; 2016 April 30-May 3, 2016; Baltimore, MD: Pediatric Academic Societies.
128. Seelig, M., Vitamin D and cardiovascular, renal and brain damage in infancy and childhood. Ann. N. Y. Acad. Sci. 147 (1969), 537–582.
129. Seino, Y., Ishida, M., Yamaoka, K., Ishii, T., Hiejima, T., Ikehara, C., et al. Serum calcium regulating hormones in the perinatal period. Calcif. tissue Int. 34:2 (1982), 131–135.
130. Shinki, T., Ueno, Y., DeLuca, H.F., Suda, T., Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats. Proc. Natl. Acad. Sci. U. S. A. 96:14 (1999), 8253–8258.
131. Smith, J.E., Goodman, D.S., The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. J. Clin. Invest. 50:10 (1971), 2159–2167.
132. Song, J., Li, Y., An, R., Vitamin D restores angiogenic balance and decreases tumor necrosis factor-alpha in a rat model of pre-eclampsia. J. Obstet. Gynaecol. Res. 43:1 (2017 Jan), 42–49, 10.1111/jog.13186 [Epub 2016 Nov 12].
133. Souberbielle, J.C., Cormier, C., Kindermans, C., Gao, P., Cantor, T., Forette, F., et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J. Clin. Endocrinol. Metab. 86:7 (2001), 3086–3090.
134. Steichen, J., Tsang, R., Gratton, T., Hamstra, A., DeLuca, H., Vitamin D homeostasis in the perinatal period: 1,25-dihydroxyvitamin D in maternal, cord, and neonatal blood. N. Engl. J. Med. 302:6 (1980), 315–319.
135. Stevenson, J.C., Hillyard, C.J., MacIntyre, I., Cooper, H., Whitehead, M.I., A physiological role for calcitonin: protection of the maternal skeleton. Lancet 2:8146 (1979), 769–770.
136. Stubbs, G., Henley, K., Green, J., Autism: will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings?. Med. Hypotheses 88 (2016), 74–78.
137. Taylor, A., Stern, P., Bell, N., Abnormal regulation of circulating 25-hydroxyvitamin D on the Williams syndrome. N. Engl. J. Med. 306 (1982), 972–975.
138. Tian, X.Q., Chen, T.C., Matsuoka, L.Y., Wortsman, J., Holick, M.F., Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J. Biol. Chem. 268:20 (1993), 14888–14892.
139. Tiosano, D., Gepstein, V., Vitamin D action: lessons learned from hereditary 1,25-dihydroxyvitamin-D-resistant rickets patients. Curr. Opin. Endocrinol. Diabetes Obes. 19:6 (2012), 452–459.
140. Vahdaninia, M., Mackenzie, H., Helps, S., Dean, T., Prenatal intake of vitamins and allergic outcomes in the offspring: a systematic review and meta-analysis. J. Allergy Clin. Immunol. Pract., 2016 Nov 22, 10.1016/j.jaip.2016.09.024 pii: S2213-2198(16)30425-1, [Epub ahead of print].
141. Vieth, R., Vitamin D supplementation, 25-hydroxy-vitamin D concentrations, and safety. Am. J. Clin. Nutr. 69 (1999), 842–856.
142. Vieth, R., Kessler, M.J., Pritzker, K.P., Species differences in the binding kinetics of 25-hydroxyvitamin D3 to vitamin D binding protein. Can. J. Physiol. Pharmacol. 68:10 (1990), 1368–1371.
143. Vieth, R., Bischoff-Ferrari, H., Boucher, B., Dawson-Hughes, B., Garland, C., Heaney, R., et al. The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 85 (2007), 649–650.
144. von Mutius, E., Martinez, F.D., Inconclusive results of randomized trials of prenatal vitamin D for asthma prevention in offspring: curbing the enthusiasm. JAMA 315:4 (2016), 347–348.
145. Wagner, C.L., McNeil, R., Hamilton, S.A., Winkler, J., Rodriguez Cook, C., Warner, G., et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol., 208(2), 2013 137 e1- e13.
146. Wagner, C.L., McNeil, R.B., Johnson, D.D., Hulsey, T.C., Ebeling, M., Robinson, C., et al. Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis. J. Steroid Biochem. Mol. Biol. 136 (2013), 313–320.
147. Wagner, C.L., Baggerly, C., McDonnell, S., Baggerly, K.A., French, C.B., Baggerly, L., et al. Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009-2011 rates. J. Steroid Biochem. Mol. Biol. 155:Pt B (2016), 245–251.
148. Walker, V.P., Zhang, X., Rastegar, I., Liu, P.T., Hollis, B.W., Adams, J.S., et al. Cord blood vitamin D status impacts innate immune responses. J. Clin. Endocrinol. Metab. 96:6 (2011 Jun), 1835–1843, 10.1210/jc.2010-1559 [Epub 2011 Apr 6].
149. The Vitamin D Workshop; 2016 March 29-31 Weiss, S., Wolsk, H., Mirzakhani, H., Hollis, B., Carey, V., Litonjua, A., et al. (eds.) Asthma/wheeze and Preeclampsia Outcomes in the VDAART Trial: the Influcence of Baseline and Treatment Levels of Vitamin D on Treatment Response, 2016 Boston, MA http://www.vitamindworkshop.org/.
150. Whitehouse, A.J., Holt, B.J., Serralha, M., Holt, P.G., Kusel, M.M., Hart, P.H., Maternal serum vitamin d levels during pregnancy and offspring neurocognitive development. Pediatrics 129:3 (2012), 485–493.
151. The Vitamin D Workshop; 2016 March 29-31 Wolsk, H., Harshfield, B.J., Laranjo, N., Carey, V., Weiss, S., (eds.) Vitamin D Supplementation in Pregnant Women of Different Races and the Risk of Asthma/recurrent Wheeze in the Child: Findings from the Vitamin D Antenatal Asthma Reduction Trial (VDAART), 2016 Boston, MA http://www.vitamindworkshop.org/.
152. World Health Organisation, Vitamin D Supplementation in Infants. 2014, World Health Organisation, Geneva.
153. Xue, J., Schoenrock, S.A., Valdar, W., Tarantino, L.M., Ideraabdullah, F.Y., Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Clin. Epigenetics, 8, 2016, 107.
154. Zaidi, M., Moonga, B.S., Abe, E., Calcitonin and bone formation: a knockout full of surprises. J. Clin. Invest. 110:12 (2002), 1769–1771.
155. 3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 149:7 (2008), 3656–3667.
156. Zerofsky, M., Jacoby, B., Pedersen, T., Stephensen, C.B., Daily cholecalciferol supplementation during pregnancy alters markers of regulatory immunity, inflammation, and clinical outcomes in a randomized controlled trial. J. Nutr. 146:11 (2016 Nov), 2388–2397 [Epub 2016 Sep 21].
157. Zhang, C., Qiu, C., Hu, F.B., David, R.M., van Dam, R.M., Bralley, A., et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One, 3(11), 2008, e3753.
158. Zhang, Q., Cheng, Y., He, M., Li, T., Ma, Z., Cheng, H., Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: a randomized controlled trial. Exp. Ther. Med. 12:3 (2016), 1889–1895.
159. Zhong, Y., Armbrecht, H.J., Christakos, S., Calcitonin, a regulator of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene. J. Biol. Chem. 284:17 (2009), 11059–11069.
160. Zhu, J., DeLuca, H.F., Vitamin D 25-hydroxylase - four decades of searching, are we there yet?. Arch. Biochem. Biophys. 523:1 (2012), 30–36.
161. (abstract). Vitamin D Workshop; 2016 March 29-31 Zhu, H., Wagner, C., Pan, Y., Wang, X., Shary, J., Hollis, B., et al. (eds.) Maternal Vitamin D Supplementation and Cord Blood Genome-wide DNA Methylation Analysis, 2016 Boston, MA http://www.vitamindworkshop.org/.
162. Zinser, G.M., Welsh, J., Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol. Endocrinol. 18:9 (2004), 2208–2223.